Wolf Greenfield has once again been recognized by Managing IP. The firm was ranked nationally for: Life Sciences IP PTAB Litigation In addition, the firm was ranked in all three categories—patent cont...
Scott McKeown was quoted by Law360 in an article titled “PTAB Limits On Amendment Rejections Spur Quality Worries.” Read more (subscription required).
Wolf Greenfield has once again been recognized by the IAM Patent 1000: The World’s Leading Patent Professionals. The firm was ranked nationally for prosecution. Rich Giunta, chair of the firm's Post-G...
Nathan Speed was included in the 2020 edition of the IAM Strategy 300: The World’s Leading IP Strategists. The IAM Strategy 300 identifies individuals who are leading the way in the development and im...
We are pleased to announce that Wolf Greenfield recently completed a successful fundraising campaign supporting the Greater Boston Legal Services (GBLS) Associates Fund Drive. For the eighth year in a...
John Strand was quoted by Managing IP in an article titled “Booking.com SCOTUS victory raises survey status.” Read more (subscription required).
In an interview with American Healthcare Leader, Ed Gates shares his journey to becoming an IP lawyer and how the firm has grown since joining in 1984. Read the full interview here.
Heather DiPietrantonio was quoted by Bloomberg Law in article titled “Regeneron Hybrid Mouse Patents Called Invalid By Top UK Court.” Read more (subscription required).
Scott McKeown was quoted by Managing Intellectual Property in an article titled “How Attorneys Can Get Back PTAB Fees.” Read more (subscription required).
Wolf Greenfield was ranked again in The Legal 500 United States. The firm was listed in the category of “Patents: prosecution (including reexamination and post-grant proceedings)” and was recognized a...
Scott McKeown was quoted by Bloomberg Law in an article titled “Collateral Agreements Must Be Filed, Patent Office Says.” Read more (subscription required).
Dan Young was quoted by Law360 in an article titled “Pandemic Collaborations Pose Risk Of Future Patent Disputes.” Read more (subscription required).